Skip to Content
You are currently on the new version of our website. Access the old version .

Cancers, Volume 13, Issue 17

2021 September-1 - 250 articles

Cover Story: Immunotherapeutic agents are an attractive treatment option for children with acute myeloid leukemia (AML), yet none of these agents have been approved for pediatric nor adult AML. Koedijk et al. provide an overview of the immune composition of the bone marrow and peripheral blood in pediatric AML. The authors advocate extensive immune profiling efforts during conventional therapy as well as in immunotherapy trials to define suitable timepoints for immunotherapy intervention and to identify children most likely to benefit from these agents. Furthermore, separate pediatric studies are needed since differences in pathophysiology and maturation of the immune system and the substantially higher incidence of fusion gene drivers in pediatric AML may affect immune profiles. Implementation of optimized immunotherapeutic interventions may substantially improve patient care and outcome. View this paper.
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (250)

  • Systematic Review
  • Open Access
58 Citations
7,023 Views
21 Pages

6 September 2021

Exercise therapy is a common supportive strategy in curative cancer treatment with strong evidence regarding its positive effects on, for example, cancer-related fatigue, health- related quality of life, and physical function. In the field of advance...

  • Review
  • Open Access
2 Citations
7,192 Views
18 Pages

6 September 2021

Myeloma is a common haematological malignancy in which adverse skeletal related events are frequently seen. Over recent years, treatment for myeloma has evolved leading to improved survival. Antiresorptive therapy is an important adjunct therapy to r...

  • Article
  • Open Access
44 Citations
4,779 Views
14 Pages

Poor Neutralizing Antibody Responses in 132 Patients with CLL, NHL and HL after Vaccination against SARS-CoV-2: A Prospective Study

  • Evangelos Terpos,
  • Maria Gavriatopoulou,
  • Despina Fotiou,
  • Chara Giatra,
  • Ioannis Asimakopoulos,
  • Maria Dimou,
  • Aimilia D. Sklirou,
  • Ioannis Ntanasis-Stathopoulos,
  • Ismini Darmani and
  • Meletios A. Dimopoulos
  • + 8 authors

6 September 2021

Emerging data suggest suboptimal antibody responses to COVID-19 vaccination in patients with hematological malignancies. We evaluated the humoral response following the BNT162b2 vaccine in patients with chronic lymphocytic leukemia (CLL), non-Hodgkin...

  • Article
  • Open Access
3 Citations
2,711 Views
10 Pages

Colorectal Cancer Screening Outcomes of 2412 Prostate Cancer Patients Considered for Carbon Ion Radiotherapy

  • Nao Kobayashi,
  • Takahiro Oike,
  • Nobuteru Kubo,
  • Yuhei Miyasaka,
  • Tatsuji Mizukami,
  • Hiro Sato,
  • Akiko Adachi,
  • Hiroyuki Katoh,
  • Hidemasa Kawamura and
  • Tatsuya Ohno

6 September 2021

Colorectal cancer (CRC) screening is effective for detecting cancer in average-risk adults. For prostate cancer (PCa) patients considered for carbon ion radiotherapy (CIRT), pre-treatment CRC screening is performed empirically to avoid post-treatment...

  • Review
  • Open Access
8 Citations
3,713 Views
9 Pages

Papillary Thyroid Carcinoma with Desmoid-Type Fibromatosis: Review of Published Cases

  • Abdallah Roukain,
  • Stefano La Rosa,
  • Massimo Bongiovanni,
  • Marie Nicod Lalonde,
  • Valérie Cristina,
  • Michael Montemurro,
  • Stephane Cochet,
  • Alexandra Luquain,
  • Peter A. Kopp and
  • Gerasimos P. Sykiotis

6 September 2021

Desmoid-type fibromatosis (DTF) is a very rare variant of papillary thyroid carcinoma (PTC). It is essentially a dual tumor with a component of classical PTC with malignant epithelial proliferation (BRAF-mutated) and another component of mesenchymal...

  • Article
  • Open Access
50 Citations
9,654 Views
25 Pages

In Vitro and In Vivo Enhancement of Temozolomide Effect in Human Glioblastoma by Non-Invasive Application of Cold Atmospheric Plasma

  • Vikas Soni,
  • Manish Adhikari,
  • Hayk Simonyan,
  • Li Lin,
  • Jonathan H. Sherman,
  • Colin N. Young and
  • Michael Keidar

6 September 2021

Glioblastoma (GBM) is one of the most aggressive forms of adult brain cancers and is highly resistant to treatment, with a median survival of 12–18 months after diagnosis. The poor survival is due to its infiltrative pattern of invasion into the norm...

  • Review
  • Open Access
30 Citations
8,381 Views
15 Pages

Organ-Chip Models: Opportunities for Precision Medicine in Pancreatic Cancer

  • Muhammad R. Haque,
  • Trevor H. Rempert,
  • Taslim A. Al-Hilal,
  • Chengyao Wang,
  • Abhinav Bhushan and
  • Faraz Bishehsari

6 September 2021

Pancreatic Ductal Adenocarcinoma (PDAC) is an expeditiously fatal malignancy with a five-year survival rate of 6–8%. Conventional chemotherapeutics fail in many cases due to inadequate primary response and rapidly developing resistance. This treatmen...

  • Review
  • Open Access
65 Citations
7,711 Views
19 Pages

MYC Rules: Leading Glutamine Metabolism toward a Distinct Cancer Cell Phenotype

  • Vincent Tambay,
  • Valérie-Ann Raymond and
  • Marc Bilodeau

6 September 2021

Metabolic reprogramming and deregulated cellular energetics are hallmarks of cancer. The aberrant metabolism of cancer cells is thought to be the product of differential oncogene activation and tumor suppressor gene inactivation. MYC is one of the mo...

  • Review
  • Open Access
8 Citations
5,186 Views
18 Pages

Targeting CD82/KAI1 for Precision Therapeutics in Surmounting Metastatic Potential in Breast Cancer

  • Maximillian Viera,
  • George Wai Cheong Yip,
  • Han-Ming Shen,
  • Gyeong Hun Baeg and
  • Boon Huat Bay

6 September 2021

Metastasis is the main cause of mortality in breast cancer patients. There is an unmet need to develop therapies that can impede metastatic spread. Precision oncology has shown great promise for the treatment of cancers, as the therapeutic approach i...

  • Article
  • Open Access
6 Citations
3,042 Views
25 Pages

Prognostic and Therapeutic Potential of the OIP5 Network in Papillary Renal Cell Carcinoma

  • Mathilda Jing Chow,
  • Yan Gu,
  • Lizhi He,
  • Xiaozeng Lin,
  • Ying Dong,
  • Wenjuan Mei,
  • Anil Kapoor and
  • Damu Tang

6 September 2021

Papillary renal cell carcinoma (pRCC) is an aggressive but minor type of RCC. The current understanding and management of pRCC remain poor. We report here OIP5 being a novel oncogenic factor and possessing robust prognostic values and therapeutic pot...

  • Article
  • Open Access
12 Citations
5,260 Views
16 Pages

Subpopulations of Circulating Cells with Morphological Features of Malignancy Are Preoperatively Detected and Have Differential Prognostic Significance in Non-Small Cell Lung Cancer

  • Emanuela Fina,
  • Davide Federico,
  • Pierluigi Novellis,
  • Elisa Dieci,
  • Simona Monterisi,
  • Federica Cioffi,
  • Giuseppe Mangiameli,
  • Giovanna Finocchiaro,
  • Marco Alloisio and
  • Giulia Veronesi

6 September 2021

Background: Non-small cell lung cancer (NSCLC) frequently presents when surgical intervention is no longer feasible. Despite local treatment with curative intent, patients might experience disease recurrence. In this context, accurate non-invasive bi...

  • Article
  • Open Access
19 Citations
5,836 Views
25 Pages

6 September 2021

Melanoma is the most invasive skin cancer with the highest risk of death. While it is a serious skin cancer, it is highly curable if detected early. Melanoma diagnosis is difficult, even for experienced dermatologists, due to the wide range of morpho...

  • Article
  • Open Access
12 Citations
6,651 Views
16 Pages

Oncofetal Chondroitin Sulfate Is a Highly Expressed Therapeutic Target in Non-Small Cell Lung Cancer

  • Htoo Zarni Oo,
  • Zoltan Lohinai,
  • Nastaran Khazamipour,
  • Joey Lo,
  • Gunjan Kumar,
  • Jessica Pihl,
  • Hans Adomat,
  • Noushin Nabavi,
  • Hakhamanesh Behmanesh and
  • Mads Daugaard
  • + 14 authors

6 September 2021

Broad-spectrum therapeutics in non-small cell lung cancer (NSCLC) are in demand. Most human solid tumors express proteoglycans modified with distinct oncofetal chondroitin sulfate (CS) chains that can be detected and targeted with recombinant VAR2CSA...

  • Review
  • Open Access
48 Citations
4,962 Views
22 Pages

6 September 2021

Prostate cancer (PCa) is one of the most prevalent cancer types in males and the consequences of its distant metastatic deposits are the leading cause of PCa mortality. Therefore, identifying the causes and molecular mechanisms of hematogenous metast...

  • Article
  • Open Access
22 Citations
5,811 Views
19 Pages

The Expression Profiles and Deregulation of UDP-Glycosyltransferase (UGT) Genes in Human Cancers and Their Association with Clinical Outcomes

  • Dong Gui Hu,
  • Shashikanth Marri,
  • Peter I. Mackenzie,
  • Julie-Ann Hulin,
  • Ross A. McKinnon and
  • Robyn Meech

6 September 2021

The human UDP-glycosyltransferase (UGTs) superfamily has 22 functional enzymes that play a critical role in the metabolism of small lipophilic compounds, including carcinogens, drugs, steroids, lipids, fatty acids, and bile acids. The expression prof...

  • Article
  • Open Access
3 Citations
3,924 Views
14 Pages

Intracranial Treatment in Melanoma Patients with Brain Metastasis Is Associated with Improved Survival in the Era of Immunotherapy and Anti-BRAF Therapy

  • Céline Dalmasso,
  • Cécile Pagès,
  • Léonor Chaltiel,
  • Vincent Sibaud,
  • Elisabeth Moyal,
  • Ciprian Chira,
  • Jean Christophe Sol,
  • Igor Latorzeff,
  • Nicolas Meyer and
  • Anouchka Modesto

6 September 2021

Metastatic melanoma patients are at high risk of brain metastases (BM). Although intracranial control is a prognostic factor for survival, impact of local (intracranial) treatment (LT), surgery and/or radiotherapy (stereotactic or whole brain) in the...

  • Feature Paper
  • Review
  • Open Access
25 Citations
5,643 Views
21 Pages

Hybrid Formation and Fusion of Cancer Cells In Vitro and In Vivo

  • Ralf Hass,
  • Juliane von der Ohe and
  • Thomas Dittmar

6 September 2021

The generation of cancer hybrid cells by intra-tumoral cell fusion opens new avenues for tumor plasticity to develop cancer stem cells with altered properties, to escape from immune surveillance, to change metastatic behavior, and to broaden drug res...

  • Article
  • Open Access
6 Citations
3,568 Views
19 Pages

Development of Multi-Scale X-ray Fluorescence Tomography for Examination of Nanocomposite-Treated Biological Samples

  • Si Chen,
  • Ruben Omar Lastra,
  • Tatjana Paunesku,
  • Olga Antipova,
  • Luxi Li,
  • Junjing Deng,
  • Yanqi Luo,
  • Michael Beau Wanzer,
  • Jelena Popovic and
  • Gayle E. Woloschak
  • + 4 authors

6 September 2021

Research in cancer nanotechnology is entering its third decade, and the need to study interactions between nanomaterials and cells remains urgent. Heterogeneity of nanoparticle uptake by different cells and subcellular compartments represent the grea...

  • Review
  • Open Access
192 Citations
14,729 Views
17 Pages

6 September 2021

The present review highlights the complex interactions between cancer and neutrophil extracellular traps (NETs). Neutrophils constitute the first line of defense against foreign invaders using major effector mechanisms: phagocytosis, degranulation, a...

  • Article
  • Open Access
9 Citations
3,701 Views
18 Pages

5 September 2021

Using a machine learning approach with a gene expression profile, we discovered a tumor nonimmune-microenvironment-related gene expression signature, including extracellular matrix (ECM) remodeling, epithelial–mesenchymal transition (EMT), and angiog...

  • Review
  • Open Access
20 Citations
5,254 Views
16 Pages

5 September 2021

Osteosarcoma (OS) is the most common malignant bone tumor, arising mainly in children and adolescents. With the introduction of multiagent chemotherapy, the treatments of OS have remarkably improved, but the prognosis for patients with metastases is...

  • Review
  • Open Access
8 Citations
4,843 Views
17 Pages

5 September 2021

Despite the significant advances in the treatment of high-risk prostate cancer, patients with very high-risk features such as being locally advanced (clinical stage T3–4 or minimal nodal involvement), having a high Gleason pattern, or with oligometas...

  • Review
  • Open Access
21 Citations
6,438 Views
25 Pages

5 September 2021

Cancer cells continuously interact with the tumor microenvironment (TME), a heterogeneous milieu that surrounds the tumor mass and impinges on its phenotype. Among the components of the TME, blood vessels and peripheral nerves have been extensively s...

  • Article
  • Open Access
5 Citations
2,735 Views
20 Pages

5 September 2021

Oxaliplatin plays a significant role as a chemotherapeutic agent for the treatment of colorectal cancer (CRC); however, oxaliplatin-resistant phenotypes make further treatment challenging. Here, we have demonstrated that rapid (60 s) hyperthermia (42...

  • Article
  • Open Access
16 Citations
3,566 Views
17 Pages

Necroptosis in Esophageal Squamous Cell Carcinoma: An Independent Prognostic Factor and Its Correlation with Tumor-Infiltrating Lymphocytes

  • Takuro Yamauchi,
  • Fumiyoshi Fujishima,
  • Masatoshi Hashimoto,
  • Junichi Tsunokake,
  • Ryujiro Akaishi,
  • Yusuke Gokon,
  • Shunsuke Ueki,
  • Yohei Ozawa,
  • Toshiaki Fukutomi and
  • Hironobu Sasano
  • + 6 authors

5 September 2021

Necroptosis is a pivotal process in cancer biology; however, the clinical significance of necroptosis in esophageal squamous cell carcinoma (ESCC) has remained unknown. Therefore, in this study, we aimed to verify the potential involvement of necropt...

  • Article
  • Open Access
11 Citations
4,191 Views
19 Pages

Targeting S1PR1 May Result in Enhanced Migration of Cancer Cells in Bladder Carcinoma

  • Chin-Li Chen,
  • En Meng,
  • Sheng-Tang Wu,
  • Hsing-Fan Lai,
  • Yi-Shan Lu,
  • Ming-Hsin Yang,
  • Chih-Wei Tsao,
  • Chien-Chang Kao and
  • Yi-Lin Chiu

5 September 2021

Clinical bladder tumor histological analysis shows that high expression of S1PR1 is associated with poor patient prognosis. However, there are no studies that describe the underlying mechanism. To investigate the relative distribution and actual func...

  • Article
  • Open Access
14 Citations
4,176 Views
13 Pages

The Hidden Treasures of Preoperative Blood Assessment in Oral Cancer: A Potential Source of Biomarkers

  • Ana Caruntu,
  • Liliana Moraru,
  • Mihai Lupu,
  • Lacramioara Taubner,
  • Constantin Caruntu and
  • Cristiana Tanase

5 September 2021

(1) Background: Oral squamous cell carcinoma (OSCC) is a common malignancy, and the impact of immune and inflammatory mechanisms in its development and progression are of major interest. The aim of our study is to assess the prognostic potential of c...

  • Article
  • Open Access
12 Citations
7,713 Views
23 Pages

Combining APR-246 and HDAC-Inhibitors: A Novel Targeted Treatment Option for Neuroblastoma

  • Michael Müller,
  • Lisa Rösch,
  • Sara Najafi,
  • Charlotte Gatzweiler,
  • Johannes Ridinger,
  • Xenia F. Gerloff,
  • David T. W. Jones,
  • Jochen Baßler,
  • Sina Kreth and
  • Ina Oehme
  • + 7 authors

5 September 2021

APR-246 (Eprenetapopt/PRIMA-1Met) is a very potent anti-cancer drug in clinical trials and was initially developed as a p53 refolding agent. As an alternative mode of action, the elevation of reactive oxygen species (ROS) has been proposed. Through a...

  • Systematic Review
  • Open Access
28 Citations
9,671 Views
24 Pages

5 September 2021

Twenty additional years of epidemiologic literature have become available since the publication of two meta-analyses on farming and brain cancer in 1998. The current systematic literature review and meta-analysis extends previous research and harmoni...

  • Guidelines
  • Open Access
76 Citations
23,574 Views
27 Pages

Best Practices for Spatial Profiling for Breast Cancer Research with the GeoMx® Digital Spatial Profiler

  • Helga Bergholtz,
  • Jodi M. Carter,
  • Alessandra Cesano,
  • Maggie Chon U Cheang,
  • Sarah E. Church,
  • Prajan Divakar,
  • Christopher A. Fuhrman,
  • Shom Goel,
  • Jingjing Gong and
  • on behalf of the GeoMx Breast Cancer Consortium
  • + 23 authors

4 September 2021

Breast cancer is a heterogenous disease with variability in tumor cells and in the surrounding tumor microenvironment (TME). Understanding the molecular diversity in breast cancer is critical for improving prediction of therapeutic response and progn...

  • Article
  • Open Access
7 Citations
3,476 Views
16 Pages

Kv1.3 Controls Mitochondrial Dynamics during Cell Cycle Progression

  • Jesusa Capera,
  • Mireia Pérez-Verdaguer,
  • María Navarro-Pérez and
  • Antonio Felipe

4 September 2021

The voltage-gated potassium channel Kv1.3 is a potential therapeutic target for obesity and diabetes. The genetic ablation and pharmacological inhibition of Kv1.3 lead to a lean phenotype in rodents. The mechanism of regulation of body weight and ene...

  • Article
  • Open Access
14 Citations
3,699 Views
16 Pages

Increased Sensitivity of Detection of RASSF1A and GSTP1 DNA Fragments in Serum of Prostate Cancer Patients: Optimisation of Diagnostics Using OBBPA-ddPCR

  • Markus Friedemann,
  • Friederike Horn,
  • Katharina Gutewort,
  • Lars Tautz,
  • Carsten Jandeck,
  • Nicole Bechmann,
  • Olga Sukocheva,
  • Manfred P. Wirth,
  • Susanne Fuessel and
  • Mario Menschikowski

4 September 2021

Identification of aberrant DNA methylation is a promising tool in prostate cancer (PCa) diagnosis and treatment. In this study, we evaluated a two-step method named optimised bias-based preamplification followed by digital PCR (OBBPA-dPCR). The metho...

  • Review
  • Open Access
32 Citations
8,280 Views
17 Pages

Insights from IgE Immune Surveillance in Allergy and Cancer for Anti-Tumour IgE Treatments

  • Alex J. McCraw,
  • Jitesh Chauhan,
  • Heather J. Bax,
  • Chara Stavraka,
  • Gabriel Osborn,
  • Melanie Grandits,
  • Jacobo López-Abente,
  • Debra H. Josephs,
  • James Spicer and
  • Silvia Crescioli
  • + 3 authors

4 September 2021

IgE, the predominant antibody class of the allergic response, is known for its roles in protecting against parasites; however, a growing body of evidence indicates a significant role for IgE and its associated effector cells in tumour immunosurveilla...

  • Article
  • Open Access
6 Citations
3,606 Views
15 Pages

4 September 2021

The major causative agents of head and neck squamous cell carcinomas (HNSCCs) are either environmental factors, such as tobacco and alcohol consumption, or infection with oncogenic human papillomaviruses (HPVs). An important aspect of HPV-induced onc...

  • Article
  • Open Access
4 Citations
4,217 Views
19 Pages

Prior Exposure to Coxsackievirus A21 Does Not Mitigate Oncolytic Therapeutic Efficacy

  • William J. Burnett,
  • David M. Burnett,
  • Gennie Parkman,
  • Andrew Ramstead,
  • Nico Contreras,
  • William Gravley,
  • Sheri L. Holmen,
  • Matthew A. Williams and
  • Matthew W. VanBrocklin

4 September 2021

Oncolytic viruses (OVs) are being developed as a type of immunotherapy and have demonstrated durable tumor responses and clinical efficacy. One such OV, Coxsackievirus A21 (CVA21), exhibited therapeutic efficacy in early phase clinical trials, demons...

  • Article
  • Open Access
6 Citations
3,474 Views
20 Pages

Elevated Flt3L Predicts Long-Term Survival in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms

  • Katharina M. Detjen,
  • Raik Otto,
  • Yvonne Giesecke,
  • Lukas Geisler,
  • Pamela Riemer,
  • Henning Jann,
  • Carsten Grötzinger,
  • Christine Sers,
  • Andreas Pascher and
  • Linda Hammerich
  • + 6 authors

4 September 2021

Background: The clinical management of high-grade gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN) is challenging due to disease heterogeneity, illustrating the need for reliable biomarkers facilitating patient stratification and guiding tre...

  • Article
  • Open Access
8 Citations
4,130 Views
18 Pages

The CDH1 c.1901C>T Variant: A Founder Variant in the Portuguese Population with Severe Impact in mRNA Splicing

  • Rita Barbosa-Matos,
  • Rafaela Leal Silva,
  • Luzia Garrido,
  • Ana Cerqueira Aguiar,
  • José Garcia-Pelaez,
  • Ana André,
  • Susana Seixas,
  • Sónia Passos Sousa,
  • Luísa Ferro and
  • Carla Oliveira
  • + 11 authors

4 September 2021

Hereditary diffuse gastric cancer (HDGC) caused by CDH1 variants predisposes to early-onset diffuse gastric (DGC) and lobular breast cancer (LBC). In Northern Portugal, the unusually high number of HDGC cases in unrelated families carrying the c.1901...

  • Article
  • Open Access
20 Citations
4,767 Views
12 Pages

One-Step Nucleic Acid Amplification (OSNA) of Sentinel Lymph Node in Early-Stage Endometrial Cancer: Spanish Multicenter Study (ENDO-OSNA)

  • María Dolores Diestro,
  • Alberto Berjón,
  • Ignacio Zapardiel,
  • Laura Yébenes,
  • Irune Ruiz,
  • Arantza Lekuona,
  • Marta Rezola,
  • Ibon Jaunarena,
  • Jaime Siegrist and
  • David Hardisson
  • + 24 authors

4 September 2021

The objective of this study was to evaluate the efficacy of one-step nucleic acid amplification (OSNA) for the detection of sentinel lymph node (SLN) metastasis compared to standard pathological ultrastaging in patients with early-stage endometrial c...

  • Review
  • Open Access
40 Citations
6,366 Views
23 Pages

The Race for Hydroxamate-Based Zirconium-89 Chelators

  • Irene V. J. Feiner,
  • Marie Brandt,
  • Joseph Cowell,
  • Tori Demuth,
  • Daniëlle Vugts,
  • Gilles Gasser and
  • Thomas L. Mindt

4 September 2021

Metallic radionuclides conjugated to biological vectors via an appropriate chelator are employed in nuclear medicine for the diagnosis (imaging) and radiotherapy of diseases. For the application of radiolabeled antibodies using positron emission tomo...

  • Article
  • Open Access
39 Citations
5,695 Views
14 Pages

Diagnostic Performance of Kwak, EU, ACR, and Korean TIRADS as Well as ATA Guidelines for the Ultrasound Risk Stratification of Non-Autonomously Functioning Thyroid Nodules in a Region with Long History of Iodine Deficiency: A German Multicenter Trial

  • Philipp Seifert,
  • Simone Schenke,
  • Michael Zimny,
  • Alexander Stahl,
  • Michael Grunert,
  • Burkhard Klemenz,
  • Martin Freesmeyer,
  • Michael C. Kreissl,
  • Ken Herrmann and
  • Rainer Görges

4 September 2021

Germany has a long history of insufficient iodine supply and thyroid nodules occur in over 30% of the adult population, the vast majority of which are benign. Non-invasive diagnostics remain challenging, and ultrasound-based risk stratification syste...

  • Review
  • Open Access
35 Citations
4,947 Views
16 Pages

Electrochemotherapy of Deep-Seated Tumors: State of Art and Perspectives as Possible “EPR Effect Enhancer” to Improve Cancer Nanomedicine Efficacy

  • Maria Cristina Bonferoni,
  • Giovanna Rassu,
  • Elisabetta Gavini,
  • Milena Sorrenti,
  • Laura Catenacci,
  • Maria Luisa Torre,
  • Sara Perteghella,
  • Luca Ansaloni,
  • Marcello Maestri and
  • Paolo Giunchedi

3 September 2021

Surgical resection is the gold standard for the treatment of many kinds of tumor, but its success depends on the early diagnosis and the absence of metastases. However, many deep-seated tumors (liver, pancreas, for example) are often unresectable at...

  • Review
  • Open Access
69 Citations
8,183 Views
17 Pages

Ovarian Cancer in the Era of Immune Checkpoint Inhibitors: State of the Art and Future Perspectives

  • Brigida Anna Maiorano,
  • Mauro Francesco Pio Maiorano,
  • Domenica Lorusso and
  • Evaristo Maiello

3 September 2021

Background: Ovarian cancer (OC) represents the eighth most common cancer and the fifth leading cause of cancer-related deaths among the female population. In an advanced setting, chemotherapy represents the first-choice treatment, despite a high recu...

  • Review
  • Open Access
30 Citations
5,164 Views
11 Pages

Leukoplakia in the Oral Cavity and Oral Microbiota: A Comprehensive Review

  • Giacomo Pietrobon,
  • Marta Tagliabue,
  • Luigi Marco Stringa,
  • Rita De Berardinis,
  • Francesco Chu,
  • Jacopo Zocchi,
  • Elena Carlotto,
  • Susanna Chiocca and
  • Mohssen Ansarin

3 September 2021

We reviewed the current published literature on the impact of oral microbiota on oral cavity leukoplakia (OLK), aiming at clarifying its role in disease transformation. The analysis unveiled that bacterial richness and diversity in the oral cavity te...

  • Review
  • Open Access
7 Citations
4,280 Views
21 Pages

In Vitro Magnetic Techniques for Investigating Cancer Progression

  • Sarah Libring,
  • Ángel Enríquez,
  • Hyowon Lee and
  • Luis Solorio

3 September 2021

Worldwide, there are currently around 18.1 million new cancer cases and 9.6 million cancer deaths yearly. Although cancer diagnosis and treatment has improved greatly in the past several decades, a complete understanding of the complex interactions b...

  • Review
  • Open Access
9 Citations
4,861 Views
20 Pages

Myeloma–Bone Interaction: A Vicious Cycle via TAK1–PIM2 Signaling

  • Takeshi Harada,
  • Masahiro Hiasa,
  • Jumpei Teramachi and
  • Masahiro Abe

3 September 2021

Multiple myeloma (MM) has a propensity to develop preferentially in bone and form bone-destructive lesions. MM cells enhance osteoclastogenesis and bone resorption through activation of the RANKL–NF-κB signaling pathway while suppressing bone formati...

  • Feature Paper
  • Review
  • Open Access
90 Citations
13,029 Views
32 Pages

The Extracellular Matrix in Pancreatic Cancer: Description of a Complex Network and Promising Therapeutic Options

  • Benedetta Ferrara,
  • Cataldo Pignatelli,
  • Mélissande Cossutta,
  • Antonio Citro,
  • José Courty and
  • Lorenzo Piemonti

3 September 2021

The stroma is a relevant player in driving and supporting the progression of pancreatic ductal adenocarcinoma (PDAC), and a large body of evidence highlights its role in hindering the efficacy of current therapies. In fact, the dense extracellular ma...

  • Article
  • Open Access
21 Citations
3,056 Views
14 Pages

The Unfolded Protein Response Is Associated with Cancer Proliferation and Worse Survival in Hepatocellular Carcinoma

  • Ankit Patel,
  • Masanori Oshi,
  • Li Yan,
  • Ryusei Matsuyama,
  • Itaru Endo and
  • Kazuaki Takabe

3 September 2021

Hepatocellular carcinoma is a leading cause of cancer death worldwide. The unfolded protein response (UPR) has been revealed to confer tumorigenic capacity in cancer cells. We hypothesized that a quantifiable score representative of the UPR could be...

  • Review
  • Open Access
82 Citations
10,443 Views
19 Pages

Normalizing Tumor Vasculature to Reduce Hypoxia, Enhance Perfusion, and Optimize Therapy Uptake

  • Kathy Matuszewska,
  • Madison Pereira,
  • Duncan Petrik,
  • Jack Lawler and
  • Jim Petrik

3 September 2021

A basic requirement of tumorigenesis is the development of a vascular network to support the metabolic requirements of tumor growth and metastasis. Tumor vascular formation is regulated by a balance between promoters and inhibitors of angiogenesis. T...

of 5

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694